Zona pellucida solubility and cortical granule complements in human oocytes following assisted reproductive techniques.
In this study the solubility to alpha-chymotrypsin of the zona pellucida (ZP) of human oocytes and polyploid embryos obtained during various clinical procedures of assisted fertilisation (IVF, ICSI, cyropreservation) was evaluated. The aim of the study was to determine whether changes in ZP solubility occur during such procedures and whether abnormal solubility could be likened to fertilisation failure. Correlation between ZP solubility and cortical granule (CG) density was also studied. The results showed that ZP solubility varied considerably among germinal vesicle or metaphase oocytes obtained from different subjects, but was essentially identical for the oocyte cohort obtained from individual women. On the basis of ZP solubility metaphase oocytes were subdivided into two classes: class I, average ZP dissolution time +/- SE = 24.1+/-0.9 min, n = 28; and class II, 46.7+/-2.0 min, n = 13. Prolonged ZP dissolution times of metaphase oocytes were significantly correlated with a low in vitro fertilisation rate in sibling oocytes. The zonae of fertilised eggs (polyploid embryos) showed long solubilisation times (IVF: 45.3+/-3.4 min, n = 18; ICSI: 48.9+/-2.7 min, n = 19). ZP solubility of oocytes that failed to fertilise was intermediate between that of class I metaphase oocytes and embryos (unfertilised IVF: 33.0+/-2.7 min, n = 13; unfertilised ICSI: 43.0+/-2.4 min, n = 9). A moderate spontaneous ZP hardening occurred when metaphase oocytes were cultured for 24 h. Finally, cryopreservation of unfertilised oocytes caused hardening of their ZP, with dissolution times that were comparable to those found in fertilised eggs (49.5+/-2.3 min, n = 10). In most cases, an inverse correlation was found between ZP dissolution time and CG density (longer solubilisation times corresponding to lower CG density). ZP hardening caused by cryopreservation, however, was not associated with a significant reduction in CG density in most of the oocytes examined.
Manna
C
C
Genesis, Centro por la Riproduzione Umana e Terapia dell'Infertilità, Rome, Italy.
Rienzi
L
L
Greco
E
E
Sbracia
M
M
Rahman
A
A
Poverini
R
R
Siracusa
G
G
De Felici
M
M
D000328:Adult; D002918:Chymotrypsin / Q000494:pharmacology; D015925:Cryopreservation; D005089:Exocytosis; D005260:Female; D005306:Fertilization; D005307:Fertilization in Vitro / Q000379:methods; D006801:Humans; D008677:Metaphase; D009865:Oocytes / Q000378:metabolism* / Q000502:physiology / Q000648:ultrastructure*; D020554:Sperm Injections, Intracytoplasmic / Q000379:methods; D013997:Time Factors; D015044:Zona Pellucida / Q000187:drug effects / Q000378:metabolism* / Q000502:physiology
D002918:Chymotrypsin; C117608:alpha-chymotrypsin